Emil von Behring was a German physiologist and physician who, working alongside Kitasato Shibasaburo at Robert Koch's Imperial Health Office in 1890, developed serum therapy, immunizing animals against diphtheria and tetanus toxins and then using their antibody-rich serum to treat afflicted patients. By 1894, refined production methods made human trials of diphtheria antitoxin dramatically successful against a disease that had been a leading cause of childhood death, and Behring went on to found a pharmaceutical company to manufacture the treatment at scale. In 1901 he received the first Nobel Prize in Physiology or Medicine ever awarded, specifically for his work on serum therapy and its application against diphtheria.
Facts
Emil von Behring
Filter Results1 entry
Connections
Discoveries
Specialist In
Emil von Behring developed diphtheria antitoxin and is called the father of serotherapy.
In the Other Atlases
Sources
1. Wikidata: Emil von Behring
- Wikidata Q76425, class allow-list match (w-wdresolver-0926)
- Wikidata P569 (w-bbfill-medicine3-0926)
View the Source2. Wikipedia: Emil von Behring
Wikimedia FoundationInfobox, Born row
Adolf Emil Behring (1854-03-15)15 March 1854 Hansdorf, Kreis Rosenberg in Westpreußen, Province of Prussia, Kingdom of Prussia, German Confederation (now Poland)
Infobox, Died row
31 March 1917(1917-03-31) (aged 63) Marburg, Hesse-Nassau, Kingdom of Prussia, German Empire
View the Source 3. Emil Adolf von Behring, Famous Scientists
Biography, birth sentence
Emil Adolf Behring was born on 15 March 1854 in Hansdorf, Germany.
Biography, death sentence
Emil Adolf von Behring died on 31 March 1917.
View the SourceFrequently Asked Questions
Why did Emil von Behring receive the first Nobel Prize in Physiology or Medicine?
In 1901 Behring received the first Nobel Prize in Physiology or Medicine ever awarded, specifically for his work on serum therapy and its application against diphtheria. He had developed serum therapy in 1890, working alongside Kitasato Shibasaburo at Robert Koch's Imperial Health Office, by immunizing animals against diphtheria and tetanus toxins and then using their antibody-rich serum to treat afflicted patients. By 1894 refined production methods made human trials of diphtheria antitoxin dramatically successful against a disease that had been a leading cause of childhood death.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.